Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

Sesame Care vs ShedRx

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Grade B+ · #3

Sesame Care

An established national telehealth marketplace carrying real brand-name GLP-1s — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — where most programs we rank carry none, plus provider-by-provider price transparency.

Visit Sesame Care
vs
Grade B+ · #4

ShedRx

Four routes to the same molecule — injection, drops, lozenges and an oral pill — plus real brand Zepbound, with health coaching bundled in.

Visit ShedRx

The verdict

Too close to call. Sesame Care and ShedRx land on the same Verdict Score of 87/100, so this one comes down to your priorities rather than our scoreboard. Weigh the factor-by-factor breakdown and pricing below — shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.

Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

86Real-world results86
80Price honesty86
92Prescriber access83
95Formulary choice90
82Cancellation fairness88
80Member support88

Price, coverage & features

MetricSesame CareShedRx
Verdict Score87/10087/100
GradeB+B+
SemaglutideFrom $149/mo (brand Wegovy pill)$199/mo
TirzepatideBrand Zepbound (price varies)$299/mo
CoverageNationwide marketplaceAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes

Sesame Care

What we like

  • Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
  • Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
  • You choose the provider and see the price up front — genuine marketplace transparency
  • Oral routes available (Wegovy pill, Rybelsus)

The caveats

  • A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
  • Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
  • Brand-name cash prices can run high without insurance

ShedRx

What we like

  • Four routes to a GLP-1 — injection, liquid drops, lozenges and an oral daily pill — plus brand Zepbound and Wegovy
  • Tirzepatide $299/mo month-to-month falling to $239 on a twelve-month plan; semaglutide $199 falling to $159
  • Health coaching included with membership rather than upsold
  • Publishes a 120-day weight-loss guarantee, which almost nothing else here offers

The caveats

  • The advertised "as low as $239" tirzepatide rate requires committing to twelve months — month-to-month is $299
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • The dispensing compounding pharmacy is not publicly named

Our pick — visit

Shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.

Visit Sesame Care Read the full Sesame Care review →

Our pick — visit

People who want options rather than one route: a needle-free form, a brand pathway, or coaching included instead of sold separately.

Visit ShedRx Read the full ShedRx review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against Sesame Care cover the 7 programs closest to it, and the same shortlist for ShedRx does the reverse.

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.